Table 2.
Plasma Concentrations of Citalopram and Prolactin
Citalopram Concentrations (ng/mL) Mean ± Standard Deviation | ||||||
---|---|---|---|---|---|---|
Controls | Depressed Older Adults | |||||
End of Infusion (EOI) | 87.8 ± 51.9 | 76.2 ± 33.5 | ||||
15 minutes Post-EOI | 56.4 ± 12.0 | 52.5 ± 14.2 | ||||
30 minutes Post-EOI | 52.2 ± 15.8 | 51.1 ± 13.3 | ||||
60 minutes Post-EOI | 48.3 ± 10.9 | 46.2 ± 13.5 | ||||
90 minutes Post-EOI | 46.3 ± 8.4 | 42.5 ± 10.5 | ||||
120 minutes Post-EOI | 43.9 ± 11.4 | 44.1 ± 13.1 | ||||
Prolactin Concentrations (ng/mL) Mean ± Standard Deviation | ||||||
Controls | Depressed Older Adults | |||||
Placebo | Citalopram | %Δ | Placebo | Citalopram | %Δ | |
Pre-Infusion | 8.1 ± 3.2 | 9.0 ± 4.6 | 6.0 ± 25.5 | 7.1 ± 2.4 | 7.8 ± 3.0 | 13.1 ± 50.1 |
End of Infusion (EOI) | 9.5 ± 4.6 | 16.3 ± 14.9 | 69.5 ± 142.0 | 7.4 ± 4.2 | 12.4 ± 7.6 | 47.3 ± 68.8 |
15 minutes Post-EOI | 9.1 ± 3.8 | 14.8 ± 13.7 | 59.8 ± 116.8 | 7.3 ± 3.7 | 11.5 ± 7.8 | 25.3 ± 52.9 |
30 minutes Post-EOI | 9.3 ± 3.9 | 15.6 ± 10.6 | 81.5 ± 125.3 | 6.9 ± 2.8 | 11.1 ± 6.1 | 39.8 ± 75.3 |
60 minutes Post-EOI | 8.7 ± 3.7 | 14.8 ± 8.5 | 81.5 ± 105.0 | 6.2 ± 2.1 | 10.5 ± 5.2 | 52.5 ± 77.2 |
90 minutes Post-EOI | 9.5 ± 4.4 | 14.1 ± 6.9 | 58.6 ± 64.0 | 6.6 ± 2.8 | 10.3 ± 4.6 | 50.6 ± 62.8 |
120 minutes Post-EOI | 10.5 ± 4.7 | 13.3 ± 6.3 | 31.5 ± 37.4 | 7.0 ± 2.6 | 11.3 ± 6.8 | 43.9 ± 47.9 |